Eudaimonia Asset Management »

Travere Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.2M 109k 38.21
2025-03-31 $2.7M 150k 17.92

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
State Street Corporation
Perceptive Advisors
Adage Capital Partners GP
FMR
Renaissance Technologies
Rock Springs Capital Management
Geode Capital Management
Goldman Sachs Group
Stephens Investment Management Group
Emerald Advisers
Point72 Asset Management

View all funds holding Travere Therapeutics